CI insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Everett Neville EVP, Special Advisor to the CEO	617	$284.05	11%	5.1K	Sep 3, 2026	Sep 8, 2026

What stands out

David Cordani bought 4.1K shares for $1000K, first on Nov 3, 2025. These are the first by current officers or directors since Aug 11, 2021.Purchase, Nov 3, 2025

David Cordani sold 33% of vested holdings: 202K shares for $59.1M, all under a disclosed plan.Largest sale, May 12, 2026

Everett Neville sold 2.3K shares (67% of starting holdings), but 5.3K more vested, so the stake grew (from 3.5K to 5.1K).Largest sale, Mar 2, 2026

Percentages cover 23 of 25 officers and directors. Left out: Nicole Jones (most holdings were last confirmed in 2018); Jamie Kates (most of their shares vested during the period, so a percentage would mislead). Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is the insider's vested stake at the start of the period (Oct 8, 2025). The gold part is what they sold.

SoldRest of starting stakeAdded during the period

David Cordani

Chairman & CEO, Director

Sold 33%, but 217K shares were added (mostly vesting), so the stake grew

33% · $59.1MDisclosed plan

Nicole Jones

EVP, Chief Administrative Officer and Chief Human Resources Officer

Sold 47% of the shares held or received (after tax withholding) during the period†. No bar against the starting stake: most of these shares arrived during the period.

$6.8MDisclosed plan

Everett Neville

EVP, Special Advisor to the CEO

67% · $672KDisclosed plan

Jamie Kates

Chief Accounting Officer

Sold 28% of the shares held or received (after tax withholding) during the period†. No bar against the starting stake: most of these shares arrived during the period.

$268KNo plan disclosed

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosed

Common questions

Is the Cigna CEO selling stock?

Yes. David Cordani sold 202K shares ($59.1M, 33% of starting holdings) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Cigna insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 99.6% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 0.4% had no disclosed plan. A trading plan schedules sales in advance.

Are any Cigna insiders buying?

Yes. 1 officer or director reported 1 purchase in the past 12 months (Form 4 code P, which includes private purchases).

How much of their stake did Cigna insiders sell?

About 23% overall. As a group they ended with more shares than they started with. That covers the 12 months to Oct 8, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold4 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
David Cordani Chairman & CEO, Director	$59.1M 202K shares	33%	Disclosed plan
Nicole Jones EVP, Chief Administrative Officer and Chief Human Resources Officer	$6.8M 24K shares	47%† i † Most of the shares Nicole Jones sold arrived during the period, so this is shares sold as a share of the 30K held at the start plus the 25K received, less 2.7K withheld by the company for taxes.	Disclosed plan
Everett Neville EVP, Special Advisor to the CEO	$672K 2.3K shares	67%	Disclosed plan
Jamie Kates Chief Accounting Officer	$268K 899 shares	28%† i † Most of the shares Jamie Kates sold arrived during the period, so this is shares sold as a share of the 1.7K held at the start plus the 1.7K received, less 132 withheld by the company for taxes.	No plan disclosed

The full ownership picture25 of 25 insiders fully reconciled · 25 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 8, 2025

Sold

Held Oct 8, 2026

Still held

David Cordani

Minor difference of 46 shares. Difference is under 0.5% of holdings. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Chairman & CEO, Director

618K

−202K

658K

+6.6%

Vesting, gifts, unvested awards and holding lines for David Cordani

+213Kshares vested or exercised

0gifted (net of own trusts)

−15Kwithheld by the company for taxes

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	127,767	57,766
GRAT	Common Stock, $.01 Par Value	334,387	440,798
Trust	Common Stock, $.01 Par Value	153,801	157,935
401(k)	Common Stock, $.01 Par Value	1,757	1,803

Additional holdings last reported Dec 20, 2018, not confirmed since: 306,646 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 305,006 shares, last reported Dec 20, 2018
401(k), Common Stock, $0.01 Par Value: 1,640 shares, last reported Dec 20, 2018

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
36,162	$336.48	Feb 28, 2034	$0
39,476	$305.86	Feb 28, 2035	$0
37,516	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Reconciliation: minor difference of 46 shares. Difference is under 0.5% of holdings.

Brian Evanko

Minor difference of 15 shares. Difference is under 0.5% of holdings. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

President and Chief Executive Officer

53K

68K

no sales

Vesting, gifts, unvested awards and holding lines for Brian Evanko

0shares vested or exercised

0gifted (net of own trusts)

−4.8Kwithheld by the company for taxes

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	52,083	41,030
401(k)	Common Stock, $.01 Par Value	904	920
GRAT	Common Stock, $.01 Par Value	0	25,614

Additional holdings last reported Dec 20, 2018, not confirmed since: 4,673 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 3,841 shares, last reported Dec 20, 2018
401(k), Common Stock, $0.01 Par Value: 832 shares, last reported Dec 20, 2018

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,677	$336.48	Feb 28, 2034	$0
19,158	$305.86	Feb 28, 2035	$0
15,082	$287.55	Feb 27, 2036	$0
6,716	$281.13	Sep 1, 2037	$20K

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Reconciliation: minor difference of 15 shares. Difference is under 0.5% of holdings.

Eric Foss

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

36K

37K

no sales

Vesting, gifts, unvested awards and holding lines for Eric Foss

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	35,914	36,696

Additional holdings last reported Dec 20, 2018, not confirmed since: 14,346 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 14,346 shares, last reported Dec 20, 2018

Jason Sadler

Started reporting during the period; starting holdings are from the Form 3. New Form 3 filed 2026-07-09; earlier filings set aside.

Officer

35K

no sales

Vesting, gifts, unvested awards and holding lines for Jason Sadler

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.
New Form 3 filed 2026-07-09; earlier filings set aside.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	34,705	34,705

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
6,257	$294.61	Feb 22, 2033	$0
5,400	$336.48	Feb 28, 2034	$0
5,791	$305.86	Feb 28, 2035	$0
3,564	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Nicole Jones

Most of this insider's holdings were last confirmed in 2018. Confirmed in the last three years: 27,331 shares. Not confirmed since: 28,013 shares, left out of this row. "Still held" is not shown because it would cover only the smaller, confirmed part.

EVP, Chief Administrative Officer and Chief Human Resources Officer

30K

−24K

27K

see note

Vesting, gifts, unvested awards and holding lines for Nicole Jones

+15Kshares vested or exercised

0gifted (net of own trusts)

−2.7Kwithheld by the company for taxes

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	28,325	25,880
401(k)	Common Stock, $.01 Par Value	1,420	1,451

Additional holdings last reported Dec 20, 2018, not confirmed since: 28,013 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 26,700 shares, last reported Dec 20, 2018
401(k), Common Stock, $0.01 Par Value: 1,313 shares, last reported Dec 20, 2018

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
9,677	$336.48	Feb 28, 2034	$0
11,176	$305.86	Feb 28, 2035	$0
8,066	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Reconciliation: minor difference of 32 shares. Difference is under 0.5% of holdings.

Donna Zarcone

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

27K

28K

no sales

Vesting, gifts, unvested awards and holding lines for Donna Zarcone

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	26,735	27,517

Additional holdings last reported Dec 20, 2018, not confirmed since: 22,663 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 22,663 shares, last reported Dec 20, 2018

Eric Wiseman

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

23K

24K

no sales

Vesting, gifts, unvested awards and holding lines for Eric Wiseman

0shares vested or exercised

0gifted (net of own trusts)

40K → 40Kunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	23,158	23,940

Additional holdings last reported Dec 20, 2018, not confirmed since: 17,250 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 17,250 shares, last reported Dec 20, 2018

David Brailer

EVP & Chief Health Officer

18K

no sales

Vesting, gifts, unvested awards and holding lines for David Brailer

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	17,525	17,525

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
11,369	$336.48	Feb 28, 2034	$0
23,222	$305.86	Feb 28, 2035	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Adam Kautzner

Started reporting during the period; starting holdings are from the Form 3.

Officer

14K

no sales

Vesting, gifts, unvested awards and holding lines for Adam Kautzner

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	13,533	13,533

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,608	$183.44	Feb 27, 2029	$162K
1,579	$192.02	Feb 26, 2030	$145K
2,008	$213.80	Feb 24, 2031	$141K
1,778	$227.02	Feb 23, 2032	$101K
3,764	$294.61	Feb 22, 2033	$0
5,955	$336.48	Feb 28, 2034	$0
8,708	$305.86	Feb 28, 2035	$0
5,628	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Matthew Perlberg

Started reporting during the period; starting holdings are from the Form 3.

Officer

9.3K

no sales

Vesting, gifts, unvested awards and holding lines for Matthew Perlberg

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	9,345	9,345

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
791	$227.02	Feb 23, 2032	$45K
3,136	$294.61	Feb 22, 2033	$0
5,658	$336.48	Feb 28, 2034	$0
6,343	$305.86	Feb 28, 2035	$0
4,643	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Bryan Holgerson

Started reporting during the period; starting holdings are from the Form 3.

President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes

7.7K

no sales

Vesting, gifts, unvested awards and holding lines for Bryan Holgerson

0shares vested or exercised

0gifted (net of own trusts)

942 → 1.9Kunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	6,957	6,957
401(k)	Common Stock, $.01 Par Value	736	736

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
1,280	$197.35	Feb 28, 2028	$111K
896	$183.44	Feb 27, 2029	$90K
915	$192.02	Feb 26, 2030	$84K
1,071	$213.80	Feb 24, 2031	$75K
1,124	$227.02	Feb 23, 2032	$64K
1,568	$294.61	Feb 22, 2033	$0
2,978	$336.48	Feb 28, 2034	$0
4,790	$305.86	Feb 28, 2035	$0
4,221	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Elder Granger

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

6.1K

no sales

Vesting, gifts, unvested awards and holding lines for Elder Granger

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	6,109	6,109

Additional holdings last reported Dec 21, 2018, not confirmed since: 723 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 723 shares, last reported Dec 21, 2018

Kathleen Mazzarella

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

6.1K

6.9K

no sales

Vesting, gifts, unvested awards and holding lines for Kathleen Mazzarella

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	6,109	6,891

Additional holdings last reported Dec 21, 2018, not confirmed since: 201 shares. Not included in any total or percentage on this page.

Direct, Common Stock, $0.01 Par Value: 201 shares, last reported Dec 21, 2018

Mark McClellan

Director

6.1K

6.9K

no sales

Vesting, gifts, unvested awards and holding lines for Mark McClellan

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	6,109	6,891

Kimberly Ross

Director

4.5K

5.3K

no sales

Vesting, gifts, unvested awards and holding lines for Kimberly Ross

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	4,512	5,294

Durga Koka

EVP, Global CIO

4.3K

6.6K

no sales

Vesting, gifts, unvested awards and holding lines for Durga Koka

0shares vested or exercised

0gifted (net of own trusts)

−949withheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	4,324	6,552

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
638	$218.25	Nov 5, 2031	$42K
634	$227.02	Feb 23, 2032	$36K
842	$294.61	Feb 22, 2033	$0
1,137	$336.48	Feb 28, 2034	$0
1,359	$305.86	Feb 28, 2035	$0
4,127	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Paul Sanford

Started reporting during the period; starting holdings are from the Form 3. New Form 3 filed 2026-07-09; earlier filings set aside.

Officer

4.1K

no sales

Vesting, gifts, unvested awards and holding lines for Paul Sanford

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.
New Form 3 filed 2026-07-09; earlier filings set aside.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	4,073	4,073

Andrea Nelson

Started reporting during the period; starting holdings are from the Form 3.

EVP, General Counsl & Corp Sec

3.9K

no sales

Vesting, gifts, unvested awards and holding lines for Andrea Nelson

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $0.01 Par Value	3,840	3,840
401(k)	Common Stock, $0.01 Par Value	72	72

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
453	$227.02	Feb 23, 2032	$26K
1,263	$294.61	Feb 22, 2033	$0
1,090	$336.48	Feb 28, 2034	$0
2,032	$305.86	Feb 28, 2035	$0
1,829	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

George Kurian

Director

3.8K

4.6K

no sales

Vesting, gifts, unvested awards and holding lines for George Kurian

0shares vested or exercised

0gifted (net of own trusts)

9.8K → 17Kunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	3,778	4,560

Everett Neville

New Form 3 filed 2025-04-09; earlier filings set aside.

EVP, Special Advisor to the CEO

3.5K

−2.3K

5.1K

+44%

Vesting, gifts, unvested awards and holding lines for Everett Neville

0shares vested or exercised

0gifted (net of own trusts)

−1.4Kwithheld by the company for taxes

12K → 12Kunvested awards, start → end

New Form 3 filed 2025-04-09; earlier filings set aside.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	3,509	5,053

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
3,622	$227.02	Feb 23, 2032	$207K
4,391	$294.61	Feb 22, 2033	$0
6,386	$305.86	Feb 28, 2035	$0
6,091	$336.48	Feb 28, 2034	$0
4,127	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Neesha Hathi

Director

3.4K

4.2K

no sales

Vesting, gifts, unvested awards and holding lines for Neesha Hathi

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	3,369	4,151

Ann Dennison

EVP, CFO

2.9K

7.7K

no sales

Vesting, gifts, unvested awards and holding lines for Ann Dennison

0shares vested or exercised

0gifted (net of own trusts)

−409withheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	2,920	7,745

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
5,806	$305.86	Feb 28, 2035	$0
5,414	$336.48	Feb 28, 2034	$0
8,066	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Philip Ozuah

Director

1.8K

2.6K

no sales

Vesting, gifts, unvested awards and holding lines for Philip Ozuah

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	1,801	2,583

Jamie Kates

Chief Accounting Officer

1.7K

−899

2.4K

not meaningful

Vesting, gifts, unvested awards and holding lines for Jamie Kates

+899shares vested or exercised

0gifted (net of own trusts)

−132withheld by the company for taxes

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	1,686	2,368

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
471	$183.44	Feb 27, 2029	$47K
644	$192.02	Feb 26, 2030	$59K
614	$213.80	Feb 24, 2031	$43K
704	$227.02	Feb 23, 2032	$40K
518	$294.61	Feb 22, 2033	$0
447	$336.48	Feb 28, 2034	$0
871	$305.86	Feb 28, 2035	$0
657	$287.55	Feb 27, 2036	$0

Estimate: options held × ($284.05 − strike price), using the most recent insider trade price on Form 4 (Sep 3, 2026), not a market close.

Michael Hennigan

Director

568

1.4K

no sales

Vesting, gifts, unvested awards and holding lines for Michael Hennigan

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock, $.01 Par Value	568	1,350

25 of 25 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (22 exactly, 3 with a minor or footnoted difference). Percentages cover 23 of 25 officers and directors. Left out: Nicole Jones (most holdings were last confirmed in 2018); Jamie Kates (most of their shares vested during the period, so a percentage would mislead). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$66.8M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $66.8M across 229,533 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $66.6M · 99.6%

0.4%

The lighter segment is sales with no plan disclosed in the filing ($268K), including tax-related sales outside a plan.

No plan disclosed · $268K

Sales with no 10b5-1 plan and no tax reference in the filing. $268K of it is Jamie Kates. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Jamie Kates, Jun 12, 2026

Taxes

25,827 shares ($7.4M) were withheld by the company for taxes, which isn't a market sale.

Purchases · 1 buyer (1 trade)

1 officer or director bought shares in this period, in 1 trade(Form 4 code P). Across all their filings on record there are 8 purchase trades.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
David Cordani Chairman & CEO, Director	202K	$59.1M	100%	88%	May 12, 2026 to May 12, 2026
Nicole Jones EVP, Chief Administrative Officer and Chief Human Resources Officer	24K	$6.8M	100%	10%	Mar 2, 2026 to Aug 18, 2026
Everett Neville EVP, Special Advisor to the CEO	2.3K	$672K	100%	1%	Mar 2, 2026 to Sep 3, 2026
Jamie Kates Chief Accounting Officer	899	$268K	0%	0.4%	Jun 12, 2026 to Jun 12, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$1.2M	$1.2M	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$59.1M	$59.1M	$0	$0
Jun 2026	$268K	$0	$0	$268K
Jul 2026	$0	$0	$0	$0
Aug 2026	$6.1M	$6.1M	$0	$0
Sep 2026	$175K	$175K	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

In line with the past 5 years. 4 insiders sold; the average is 9 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 8, 2026 Latest 12 months	230K	4	$66.8M
Oct 8, 2025 1 year earlier	78K	5	$23.8M
Oct 8, 2024 2 years earlier	218K	9	$74.3M
Oct 9, 2023 3 years earlier	102K	12	$30.5M
Oct 9, 2022 4 years earlier	234K	8	$61.9M
Oct 9, 2021 5 years earlier	594K	9	$139M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertaintyEvery officer and director reconciles

Every officer and director reconciles for this period.

David Cordani: minor difference of 46 shares. Difference is under 0.5% of holdings.

Brian Evanko: minor difference of 15 shares. Difference is under 0.5% of holdings.

Nicole Jones: minor difference of 32 shares. Difference is under 0.5% of holdings.

Inferred typo: the share class "Common Stock $0.01 Par Value" is treated as the same class as "Common Stock, $.01 Par Value" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Mark McClellan, 201 shares): old title, new title

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology653 filings from SEC EDGAR, and how we read them

All 653 Forms 3, 4 and 5 filed for Cigna (SEC CIK 1739940) from Dec 26, 2018 to Sep 8, 2026, retrieved from SEC EDGAR on Oct 8, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (19)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Noelle Eder	Mar 11, 2025	13,590 shares, last reported balance as of Mar 7, 2025
Eric Palmer	Mar 4, 2025	77,837 shares, last reported balance as of Feb 28, 2025
William DeLaney III	Aug 21, 2024	20,323 shares, last reported balance as of Aug 19, 2024
Michael Triplett	Aug 14, 2024	69,557 shares, last reported balance as of Aug 12, 2024
Hoeltzel Agoglia	May 16, 2024	6,732 shares, last reported balance as of May 14, 2024
Cynthia Ryan	Aug 31, 2023	7,657 shares, last reported balance as of Aug 30, 2023
Charles Berg	Feb 8, 2023	No balance on record
John Partridge	Apr 28, 2022	63,997 shares, last reported balance as of Apr 26, 2022
John Murabito	Mar 3, 2022	124,005 shares, last reported balance as of Mar 1, 2022
Isaiah Harris Jr.	Dec 2, 2021	36,385 shares, last reported balance as of Nov 30, 2021
Matthew Manders	Nov 23, 2021	81,265 shares, last reported balance as of Nov 19, 2021
Timothy Wentworth	May 13, 2021	168,554 shares, last reported balance as of May 12, 2021
Kristen Lauria	May 3, 2021	2,785 shares, last reported balance as of Apr 30, 2021
Steven Miller	Mar 2, 2021	44,570 shares, last reported balance as of Feb 26, 2021
William Roper	Mar 2, 2021	13,974 shares, last reported balance as of Feb 26, 2021
Roman Martinez IV	Dec 2, 2020	95,548 shares, last reported balance as of Nov 30, 2020
Mark Boxer	Mar 2, 2020	93,443 shares, last reported balance as of Feb 28, 2020
William Zollars	Sep 17, 2019	27,000 shares, last reported balance as of Sep 13, 2019
Lisa Bacus	Mar 5, 2019	45,224 shares, last reported balance as of Mar 1, 2019

Cigna insiders sold $66.8M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Cigna CEO selling stock?

Why are Cigna insiders selling?

Are any Cigna insiders buying?

How much of their stake did Cigna insiders sell?

The evidence

No plan disclosed · $268K

Taxes

Purchases · 1 buyer (1 trade)

Sales by month